Luciana Borio
Luciana Borio is an American physician and medical/public health administrator. She is a vice president at In-Q-Tel. She previously served as Director for Medical and Biodefense Preparedness at the National Security Council, Acting Chief Scientist of the U.S. Food and Drug Administration, Assistant Commissioner for Counterterrorism Policy of the FDA, and Director of FDA's Office of Counterterrorism and Emerging Threats. She is known for her work advancing clinical trials, the development of medical countermeasures for health emergencies, and the public health responses to Ebola and Zika outbreaks.
Prior to joining FDA's Center for Biologics Evaluation and Research in 2008, Borio was senior associate at the UPMC Center for Health Security and assistant professor of medicine at the University of Pittsburgh. Borio served at the United States Department of Health and Human Services as an advisor on biodefense programs, where she implemented and managed mathematical modeling projects to assess the health effects of bioterrorism on civilians and to inform medical countermeasures procurement activities for the Office of Preparedness and Response.
Borio obtained her MD in 1996 from George Washington University. She completed residency in 1999 in internal medicine at the Weill Cornell Medical Center and subsequently completed a combined fellowship in infectious diseases at Johns Hopkins University and critical care medicine at the National Institutes of Health. Borio continues to practice medicine at Johns Hopkins Hospital.
